dronabinol has been researched along with Diabetes Mellitus, Adult-Onset in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bilge, B; Bolkent, S; Yazici, ZMC | 1 |
| Bolkent, S; Coskun, ZM | 1 |
| Barrett, DA; Bell, JD; Jadoon, KA; O'Sullivan, SE; Ratcliffe, SH; Stott, C; Tan, GD; Thomas, EL | 1 |
| Haskó, G; Horváth, B; Mukhopadhyay, P; Pacher, P | 1 |
| Cani, PD; Delzenne, NM; Geurts, L; Muccioli, GG | 1 |
| Burstein, S | 1 |
| Després, JP | 1 |
3 review(s) available for dronabinol and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications.
Topics: Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Cannabinoids; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dronabinol; Endocannabinoids; Humans; Inflammation; Oxidative Stress | 2012 |
PPAR-gamma: a nuclear receptor with affinity for cannabinoids.
Topics: Azo Compounds; Diabetes Mellitus, Type 2; Dronabinol; Ligands; Lipid Metabolism; PPAR gamma; Receptors, Cannabinoid; Thiazolidinediones; Transcriptional Activation | 2005 |
The endocannabinoid system: a new target for the regulation of energy balance and metabolism.
Topics: Adipocytes; Adiponectin; Animals; Appetite Regulation; Arachidonic Acids; Cannabinoid Receptor Modulators; Carbohydrate Metabolism; Diabetes Mellitus, Type 2; Dronabinol; Eating; Endocannabinoids; Energy Metabolism; Humans; Lipid Metabolism; Obesity; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Randomized Controlled Trials as Topic; Receptor, Cannabinoid, CB1; Rimonabant | 2007 |
1 trial(s) available for dronabinol and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study.
Topics: Aged; Blood Glucose; Body Mass Index; Body Weight; Cannabidiol; Cholesterol; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Endpoint Determination; Female; Gastric Inhibitory Polypeptide; Glycated Hemoglobin; Humans; Male; Middle Aged; Pilot Projects; Triglycerides | 2016 |
3 other study(ies) available for dronabinol and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Anti-inflammatory potential of delta-9-tetrahydrocannabinol in hyperinsulinemia: an experimental study.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Diabetes Mellitus, Type 2; Dronabinol; Hyperinsulinism; Interleukin-6; NF-kappa B; Oxidants; Rats; Tumor Necrosis Factor-alpha | 2022 |
Biochemical and immunohistochemical changes in delta-9-tetrahydrocannabinol-treated type 2 diabetic rats.
Topics: Animals; Blood Glucose; Cannabinoid Receptor Agonists; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dronabinol; Drug Evaluation, Preclinical; Glucagon; Insulin; Islets of Langerhans; Lipid Metabolism; Lipoproteins; Male; Rats, Sprague-Dawley | 2014 |
Chronic endocannabinoid system stimulation induces muscle macrophage and lipid accumulation in type 2 diabetic mice independently of metabolic endotoxaemia.
Topics: Animals; Cannabinoid Receptor Agonists; Diabetes Mellitus, Type 2; Dronabinol; Endocannabinoids; Endotoxemia; Macrophages; Male; Mice; Mice, Inbred C57BL | 2013 |